News
- Author:
- Jim Kling
Publish date: March 25, 2022
CAP guidance predicted recurrence and survival, but RCPath guidance did not.
News
- Author:
- Jim Kling
Publish date: March 24, 2022
Positive phase 2 results pave the way for phase 3 studies.
News
- Author:
- Jim Kling
Publish date: March 24, 2022
A study of 2,073 patients shows nonsmokers have higher mortality rates compared with smokers.
News
- Author:
- Jim Kling
Publish date: March 24, 2022
Findings underscore the need for mammograms early in high risk premenopausal women.
News
- Author:
- Jim Kling
Publish date: March 22, 2022
Adding the tumor necrosis factor inhibitor adalimumab to methotrexate because of a lack of efficacy or tolerability produced better results than es...
News
- Author:
- Jim Kling
Publish date: March 21, 2022
The dangers of overdiagnosis are counterintuitive, but real.
News
- Author:
- Jim Kling
Publish date: March 14, 2022
Formulation designed for the esophagus could replace repurposed inhalants in eosinophilic esophagitis.
News
- Author:
- Jim Kling
Publish date: March 14, 2022
B-cell depletion following ocrelizumab or rituximab treatment often lasts longer than 6 months.
News
- Author:
- Jim Kling
Publish date: March 14, 2022
How to tailor screening based on CRC risk, and how to be sure screening is effective.
News
- Author:
- Jim Kling
Publish date: March 11, 2022
Troponin I and NT-proBNP levels were linked to cardiovascular risk independently of the Framingham Risk Score.
News
- Author:
- Jim Kling
Publish date: March 11, 2022
New therapies offer plenty of options, but evidence is sparse.
News
- Author:
- Jim Kling
Publish date: March 11, 2022
A randomized trial demonstrates how to deliver therapy at home.
News
- Author:
- Jim Kling
Publish date: March 9, 2022
A new prospective trial aims to prove that central vein sign can distinguish MS from clinical mimics.
News
- Author:
- Jim Kling
Publish date: March 8, 2022
In this high-risk study group, annual MRI screenings started at 30 years old, followed by MRI with mammogram at 40 years old.
News
- Author:
- Jim Kling
Publish date: March 8, 2022
There is a paradigm shift worldwide from upfront surgery to neoadjuvant treatment.
